200 related articles for article (PubMed ID: 15377362)
21. Cutaneous side-effects caused by Tegafur.
Revenga F
Int J Dermatol; 1999 Dec; 38(12):955-7. PubMed ID: 10671104
[No Abstract] [Full Text] [Related]
22. [Pigmentary disorders induced by anticancer agents. part I: chemotherapy].
Sibaud V; Fricain JC; Baran R; Robert C
Ann Dermatol Venereol; 2013 Mar; 140(3):183-96. PubMed ID: 23466151
[TBL] [Abstract][Full Text] [Related]
23. Laugier and Hunziker pigmentation: a lentiginous proliferation of melanocytes.
Moore RT; Chae KA; Rhodes AR
J Am Acad Dermatol; 2004 May; 50(5 Suppl):S70-4. PubMed ID: 15097932
[TBL] [Abstract][Full Text] [Related]
24. Lingual hyperpigmentation after 5-fluorouracil chemotherapy.
Co ML; Esteban MJ
BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28433985
[No Abstract] [Full Text] [Related]
25. [Several cases of non-phlebologic pigmentation of the lower extremities].
Beurey J; Barthelme D; Eich D; Weber M
Phlebologie; 1983; 36(4):321-7. PubMed ID: 6228945
[TBL] [Abstract][Full Text] [Related]
26. Multiple periungual pyogenic granulomas following systemic 5-fluorouracil.
Curr N; Saunders H; Murugasu A; Cooray P; Schwarz M; Gin D
Australas J Dermatol; 2006 May; 47(2):130-3. PubMed ID: 16637811
[TBL] [Abstract][Full Text] [Related]
27. Lethal leukoencephalopathy secondary to Tegafur, a 5-fluorouracil prodrug.
Sierra S; Luquin N; Carrato C
J Neurol Sci; 2015 Oct; 357(1-2):326-8. PubMed ID: 26242718
[No Abstract] [Full Text] [Related]
28. The significance of eccentric and central hyperpigmentation, multifocal hyper/hypopigmentation, and the multicomponent pattern in melanocytic lesions lacking specific dermoscopic features of melanoma.
Arevalo A; Altamura D; Avramidis M; Blum A; Menzies S
Arch Dermatol; 2008 Nov; 144(11):1440-4. PubMed ID: 19015418
[TBL] [Abstract][Full Text] [Related]
29. Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy.
Lee A; Ezzeldin H; Fourie J; Diasio R
Clin Adv Hematol Oncol; 2004 Aug; 2(8):527-32. PubMed ID: 16163233
[TBL] [Abstract][Full Text] [Related]
30. Oral hyperpigmentation as an initial clinical aspect of hand foot syndrome.
Santos-Leite ÉGD; Sacramento LV; Santana AM; Dantas JBL; Carrera M; Martins GB
Braz Dent J; 2022; 33(4):97-102. PubMed ID: 36043574
[TBL] [Abstract][Full Text] [Related]
31. Serpentine supravenous pigmentation. A rare vasculo-cutaneous effect induced by systemic 5-fluorouracil.
Rao R; Balachandran C
Indian J Dermatol Venereol Leprol; 2010; 76(6):714-5. PubMed ID: 21079327
[No Abstract] [Full Text] [Related]
32. Intermediate dose 5-fluorouracil-induced encephalopathy.
Kim YA; Chung HC; Choi HJ; Rha SY; Seong JS; Jeung HC
Jpn J Clin Oncol; 2006 Jan; 36(1):55-9. PubMed ID: 16436463
[TBL] [Abstract][Full Text] [Related]
33. Melan-a-positive "pseudomelanocytic nests": a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin.
Beltraminelli H; Shabrawi-Caelen LE; Kerl H; Cerroni L
Am J Dermatopathol; 2009 May; 31(3):305-8. PubMed ID: 19384076
[TBL] [Abstract][Full Text] [Related]
34. Regression of atypical nevus: an anecdotal dermoscopic observation.
Pizzichetta MA; Massone C; Soyer HP
Dermatol Surg; 2006 Oct; 32(10):1274-7. PubMed ID: 17034379
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs.
Reyes-Habito CM; Roh EK
J Am Acad Dermatol; 2014 Aug; 71(2):203.e1-203.e12; quiz 215-6. PubMed ID: 25037800
[TBL] [Abstract][Full Text] [Related]
36. 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction.
Gross K; Kircik L; Kricorian G
Dermatol Surg; 2007 Apr; 33(4):433-9; discussion 440. PubMed ID: 17430377
[TBL] [Abstract][Full Text] [Related]
37. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].
Shirasaka T; Taguchi T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis.
Ramírez-Hernández M; Martínez-Escribano JA; Martínez-Barba E; Alcolea-Rubio LA; Ibarra-Berrocal IJ
J Eur Acad Dermatol Venereol; 2006 May; 20(5):584-7. PubMed ID: 16684288
[TBL] [Abstract][Full Text] [Related]
39. Generalized pustular drug eruption caused by topical 5-fluorouracil.
Nemer KM; Solus JF; Schaffer A; Rosman IS; Lee SJ
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28834062
[No Abstract] [Full Text] [Related]
40. Drug-induced oral mucosal hyperpigmentation.
Scully C
Prim Dent Care; 1997 Jan; 4(1):35-6. PubMed ID: 10332345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
